| Original language | English |
|---|---|
| Pages (from-to) | 589-602 |
| Number of pages | 14 |
| Journal | Endocrinology and Metabolism Clinics of North America |
| Volume | 51 |
| Issue number | 3 |
| DOIs | |
| State | Published - Sep 2022 |
Bibliographical note
Funding Information:This work was supported in part by funding from the National Institutes of Health R01 HL147381 and the Department of Veterans Affairs BX004275 .
Funding
This work was supported in part by funding from the National Institutes of Health R01 HL147381 and the Department of Veterans Affairs BX004275 .
| Funders | Funder number |
|---|---|
| National Institutes of Health (NIH) | |
| U.S. Department of Veterans Affairs | I01BX004275, BX004275 |
| National Heart, Lung, and Blood Institute (NHLBI) | R01HL147381 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Cardiovascular
- Dyslipidemia
- Endocrine
- Lipids
ASJC Scopus subject areas
- Endocrinology, Diabetes and Metabolism
- Endocrinology
Fingerprint
Dive into the research topics of 'Management of Dyslipidemia in Endocrine Diseases'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver